Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
electroCore, Inc. stock logo
ECOR
electroCore
$6.09
-0.3%
$5.52
$4.47
$19.49
$45.34M0.8100,786 shs152,346 shs
Movano Inc. stock logo
MOVE
Movano
$0.68
-0.7%
$0.75
$0.51
$6.97
$4.79M0.89115,684 shs43,607 shs
Precision Optics Corp. stock logo
POCI
Precision Optics
$4.89
+1.2%
$4.56
$3.47
$6.59
$37.03M0.2516,066 shs2,897 shs
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
$85.27
-1.6%
$77.90
$40.67
$87.16
$4.37B-2.63790,302 shs506,146 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
electroCore, Inc. stock logo
ECOR
electroCore
0.00%+10.64%+5.24%+6.16%-5.63%
Movano Inc. stock logo
MOVE
Movano
0.00%+0.03%+6.05%-42.46%-85.54%
Precision Optics Corp. stock logo
POCI
Precision Optics
0.00%-1.61%+2.13%+16.79%-22.79%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.00%+4.07%+14.73%+24.40%+111.77%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
electroCore, Inc. stock logo
ECOR
electroCore
2.3004 of 5 stars
3.53.00.00.00.02.50.6
Movano Inc. stock logo
MOVE
Movano
2.705 of 5 stars
3.54.00.00.02.00.80.6
Precision Optics Corp. stock logo
POCI
Precision Optics
N/AN/AN/AN/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
4.7669 of 5 stars
4.52.00.04.63.22.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
electroCore, Inc. stock logo
ECOR
electroCore
3.00
Buy$25.50318.72% Upside
Movano Inc. stock logo
MOVE
Movano
3.00
Buy$30.004,344.44% Upside
Precision Optics Corp. stock logo
POCI
Precision Optics
0.00
N/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3.09
Buy$107.1025.60% Upside

Current Analyst Ratings Breakdown

Latest SLNO, POCI, ECOR, and MOVE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/23/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$110.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$81.00 ➝ $97.00
5/8/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$102.00 ➝ $105.00
4/24/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$93.00 ➝ $145.00
4/15/2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$100.00 ➝ $100.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
electroCore, Inc. stock logo
ECOR
electroCore
$25.18M1.79N/AN/A$1.13 per share5.39
Movano Inc. stock logo
MOVE
Movano
$1.01M4.70N/AN/A$1.11 per share0.61
Precision Optics Corp. stock logo
POCI
Precision Optics
$19.10M1.96N/AN/A$1.66 per share2.95
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/A$5.68 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
electroCore, Inc. stock logo
ECOR
electroCore
-$11.89M-$1.560.00N/AN/A-46.24%-149.04%-61.24%8/6/2025 (Estimated)
Movano Inc. stock logo
MOVE
Movano
-$23.73M-$4.070.00N/AN/A-288.42%-181.30%7/7/2025 (Estimated)
Precision Optics Corp. stock logo
POCI
Precision Optics
-$2.95M-$0.890.00N/A-32.84%-54.03%-32.48%N/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$175.85M-$4.620.00N/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)

Latest SLNO, POCI, ECOR, and MOVE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/7/2025Q1 2025
Movano Inc. stock logo
MOVE
Movano
-$0.70-$0.70N/AN/A$3.88 million$3.88 million
5/15/2025Q3 2025
Precision Optics Corp. stock logo
POCI
Precision Optics
N/A-$0.30N/A-$0.30N/A$4.19 million
5/7/2025Q1 2025
electroCore, Inc. stock logo
ECOR
electroCore
-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million
5/7/2025Q1 2025
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
-$1.14-$0.95+$0.19-$0.95N/AN/A
4/9/2025Q4 2024
Movano Inc. stock logo
MOVE
Movano
-$0.97-$0.61+$0.36-$0.61$1.50 million$0.11 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Movano Inc. stock logo
MOVE
Movano
N/AN/AN/AN/AN/A
Precision Optics Corp. stock logo
POCI
Precision Optics
N/AN/AN/AN/AN/A
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
electroCore, Inc. stock logo
ECOR
electroCore
N/A
1.52
1.30
Movano Inc. stock logo
MOVE
Movano
N/A
3.02
2.42
Precision Optics Corp. stock logo
POCI
Precision Optics
0.11
1.99
1.26
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
0.21
19.64
19.64

Institutional Ownership

CompanyInstitutional Ownership
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Movano Inc. stock logo
MOVE
Movano
16.64%
Precision Optics Corp. stock logo
POCI
Precision Optics
13.71%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
97.42%

Insider Ownership

CompanyInsider Ownership
electroCore, Inc. stock logo
ECOR
electroCore
19.70%
Movano Inc. stock logo
MOVE
Movano
13.40%
Precision Optics Corp. stock logo
POCI
Precision Optics
16.30%
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
6.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
electroCore, Inc. stock logo
ECOR
electroCore
507.42 million5.96 millionNot Optionable
Movano Inc. stock logo
MOVE
Movano
307.04 million6.09 millionNot Optionable
Precision Optics Corp. stock logo
POCI
Precision Optics
807.67 million6.42 millionNot Optionable
Soleno Therapeutics, Inc. stock logo
SLNO
Soleno Therapeutics
3050.39 million47.17 millionOptionable

Recent News About These Companies

SLNO Soleno Therapeutics, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
electroCore stock logo

electroCore NASDAQ:ECOR

$6.09 -0.02 (-0.33%)
As of 04:00 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Movano stock logo

Movano NASDAQ:MOVE

$0.68 -0.01 (-0.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.68 0.00 (0.00%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

Precision Optics stock logo

Precision Optics NASDAQ:POCI

$4.89 +0.06 (+1.24%)
As of 04:00 PM Eastern

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Soleno Therapeutics stock logo

Soleno Therapeutics NASDAQ:SLNO

$85.27 -1.38 (-1.59%)
Closing price 04:00 PM Eastern
Extended Trading
$85.23 -0.04 (-0.05%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.